Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Michaela, Kotrova"'
Autor:
Miriam Kelm, Franziska Darzentas, Nikos Darzentas, Michaela Kotrova, Wiebke Wessels, Sonja Bendig, Claudia D. Baldus, Marcus Lettau, Nicola Gökbuget, Dieter Kabelitz, Monika Brüggemann, Guranda Chitadze
Publikováno v:
HemaSphere, Vol 7, Iss 9, p e948 (2023)
Externí odkaz:
https://doaj.org/article/521747568a5d4e879b2f590e55e36e39
Autor:
Alexander Quaas, Hans Anton Schlößer, Michael von Bergwelt-Baildon, Martin Thelen, Birgit Gathof, Axel M Hillmer, Christiane Bruns, Diandra Keller, Jonas Lehmann, Kerstin Wennhold, Hendrik Weitz, Eugen Bauer, Monika Brüggemann, Michaela Kotrova, Christoph Mallmann, Seung-Hun Chon, Maria Alejandra Garcia-Marquez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 12 (2022)
Background Specific immune response is a hallmark of cancer immunotherapy and shared tumor-associated antigens (TAAs) are important targets. Recent advances using combined cellular therapy against multiple TAAs renewed the interest in this class of a
Externí odkaz:
https://doaj.org/article/423107d49a7e4237a30cf566c4c26b59
Autor:
Monika Brüggemann, Michaela Kotrova
Publikováno v:
Blood Advances, Vol 1, Iss 25, Pp 2456-2466 (2017)
Abstract: Nowadays, minimal residual disease (MRD) is accepted as the strongest independent prognostic factor in acute lymphoblastic leukemia (ALL). It can be detected by molecular methods that use leukemia-specific or patient-specific molecular mark
Externí odkaz:
https://doaj.org/article/8c471f64ef554e47a5331275f3ac1ccf
Autor:
Petra, Dytrych, Petra, Krol, Michaela, Kotrova, Daniela, Kuzilkova, Petr, Hubacek, Ladislav, Krol, Rami, Katra, Ondrej, Hrusak, Zdenek, Kabelka, Pavla, Dolezalova, Tomas, Kalina, Eva, Fronkova
Publikováno v:
In Molecular Immunology May 2015 65(1):139-147
Autor:
Guranda Chitadze, Anna Stengel, Cathrin John-Klaua, Julien Bruckmüller, Heiko Trautmann, Michaela Kotrova, Franziska Darzentas, Miriam Kelm, Karol Pal, Nikos Darzentas, Lorenz Bastian, Britta Kehden, Wiebke Wessels, Aeint-Steffen Ströh, Hans-Heinrich Oberg, Philipp M. Altrock, Constance Baer, Manja Meggendorfer, Nicola Gökbuget, Claudia D. Baldus, Claudia Haferlach, Monika Brüggemann
Publikováno v:
Blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79bf9011acde4283062e1869df7c504e
https://pubmed.ncbi.nlm.nih.gov/36450137
https://pubmed.ncbi.nlm.nih.gov/36450137
Autor:
Michael Svaton, Aneta Skotnicova, Leona Reznickova, Andrea Rennerova, Tatana Valova, Michaela Kotrova, Vincent H. J. van der Velden, Monika Brüggemann, Nikos Darzentas, Anton W. Langerak, Jan Zuna, Jan Stary, Jan Trka, Eva Fronkova
Publikováno v:
Blood 141(5), 529-533. (2023)
Blood, 141(5), 529-533. American Society of Hematology
Blood, 141(5), 529-533. American Society of Hematology
We compared minimal/measurable residual disease (MRD) levels evaluated by routinely used real-time quantitative polymerase chain reaction (qPCR) patient-specific assays and by next-generation sequencing (NGS) approach in 780 immunoglobulin (IG) and T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4fde81c7cd2110c4840621d8872f7d8
https://pubmed.ncbi.nlm.nih.gov/36240445
https://pubmed.ncbi.nlm.nih.gov/36240445
Autor:
Michaela Kotrova, H J M Göx, Jan Dürig, Dimitrios Mougiakakos, J Makalowski, Prerana Wagle, T Neumann, Till Braun, Sebastian Oberbeck, Alexandra Schrader, Hinrich Abken, Monika Brüggemann, Marco Herling, Richard Moriggl, Martin Thelen, A Kondo Ados, Petra Mayer, Janine Altmüller, Tero Aittokallio, Sylvia Hartmann, Sebastian Newrzela, Linus Wahnschaffe, Thorsten Persigehl, Giuliano Crispatzu, Natali Pflug, Georg Hopfinger, Michael Hallek, Kathrin Warner, Alyssa Bouska, L. Varghese, M. L. Hansmann, Javeed Iqbal, J. von Jan, S. Pützer, Ingo Roeder, T A Müller, Gunter Rappl, M von Bergwelt-Baildon, S. Stilgenbauer, D Jungherz, Hans H. Diebner, Aleksandr Ianevski, Nicole Riet, Markus Chmielewski, Hans A. Schlößer
Publikováno v:
Blood. 136:2786-2802
T-cell prolymphocytic leukemia (T-PLL) is a poor-prognostic neoplasm. Differentiation stage and immune-effector functions of the underlying tumor cell are insufficiently characterized. Constitutive activation of the T-cell leukemia 1A (TCL1A) oncogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6af64ce39db685c4e812b3f0cf2c9e2b
https://doi.org/10.1182/blood.2019003348
https://doi.org/10.1182/blood.2019003348
Autor:
Nikos Darzentas, Tobias Hutzenlaub, Michaela Kotrova, Roland Zengerle, Jacob Friedrich Hess, Nils Paust, Monika Brüggemann, Silvia Calabrese
Publikováno v:
Analytical Chemistry. 92:12833-12841
Next-generation sequencing (NGS) has become a mainstream method in bioanalysis. Improvements in sequencing and bioinformatics turned the complex and cumbersome library preparation to the bottleneck in terms of reproducibility and costs in the complet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b5424d9babebec0886f3d491d1f574
https://doi.org/10.1021/acs.analchem.0c01202
https://doi.org/10.1021/acs.analchem.0c01202
Autor:
Martin Thelen, Diandra Keller, Jonas Lehmann, Kerstin Wennhold, Hendrik Weitz, Eugen Bauer, Birgit Gathof, Monika Brüggemann, Michaela Kotrova, Alexander Quaas, Christoph Mallmann, Seung-Hun Chon, Axel M Hillmer, Christiane Bruns, Michael von Bergwelt-Baildon, Maria Alejandra Garcia-Marquez, Hans Anton Schlößer
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e005200
BackgroundSpecific immune response is a hallmark of cancer immunotherapy and shared tumor-associated antigens (TAAs) are important targets. Recent advances using combined cellular therapy against multiple TAAs renewed the interest in this class of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3d5ace2d98493692e98ca4a6420c275
https://doi.org/10.1136/jitc-2022-005200
https://doi.org/10.1136/jitc-2022-005200
Autor:
Antonia Volland, Monika Brüggemann, Stefan Schwartz, Britta Kehden, Claudia D. Baldus, Nicola Gökbuget, Michaela Kotrova, Ralph Wäsch, Heiko Trautmann, Andreas Viardot, Matthias Ritgen, Christoph Faul
Publikováno v:
Leukemia. 34:1154-1157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1610ba8f573c968a3e3624eb326efe5
https://doi.org/10.1038/s41375-019-0599-1
https://doi.org/10.1038/s41375-019-0599-1